Empowering

Precision Medicine Through Gut Microbiome Insights

At AMILI, we bring cutting-edge science to the forefront of healthcare with our Gut Health Test (GHT) Screening. Using Southeast Asia’s largest multi-ethnic microbiome database, our gut health screening delivers actionable insights to help healthcare professionals make informed decisions about patient care.

What is the GHT

Screening

?

The Gut Health Test (GHT) is a microbiome screening tool developed by AMILI, designed to provide healthcare professionals with actionable insights tailored to their patients' gut health needs. Your patient gives a stool sample and receives a report in 2-3 weeks.

Powered by a Unique Asian Database

Unlike one-size-fits-all approaches, the GHT utilises AMILI’s proprietary multi-ethnic Asian microbiome database—the first of its kind in the region. This ensures insights are highly relevant and reflect the diverse gut microbiome profiles found across Asian populations.

Next Generation Sequencing Technology

A simple stool sample undergoes precise sequencing to identify bacterial type, abundance, and diversity, delivering a detailed understanding of the patient’s microbiome composition.

Science-Driven Insights

Each test is backed by the latest peer-reviewed research, informed by studies conducted in collaboration with AMILI’s research partners and in-house team. This ensures recommendations are grounded in robust science.

Actionable Reporting for Better Care

The results are translated into a clear, comprehensive report, providing you with the tools to explain the findings to your patients and guide them toward personalised interventions and improved health outcomes.

Key Features

of GHT Screening?

Comprehensive Analysis

Stool sample collection and 16S rRNA gene sequencing for large-scale bacterial identification without the need for culture.

Proprietary Insights

Powered by AMILI’s extensive microbiome database, offering a taxonomic overview of your patient’s gut microbiome.

Biomarker Reporting

Includes over 20 biomarkers across three critical health pathways:

  • Gut Brain Axis

    : Brain-gut interactions and mental well-being.

  • Immune and Metabolic Health

    : Inflammatory response and immune modulation.

  • Digestive Health

    :  Key markers for weight regulation, nutrient metabolism and chronic disease risk.

Risk Profiling

Personalised insights by comparing patient microbiomes to disease-associated profiles, guiding targeted interventions.

Personalised food recommendations

Powered by AMILI’s research into functional foods, your unique microbiome profile will be matched with the foods best for you and your health.

Understanding

the Gut Microbiome

The gut microbiome is a diverse community of trillions of microorganisms living in the digestive tract. These microbes are essential for:

  • Breaking down food and absorbing nutrients.

  • Regulating immunity and fighting harmful pathogens.

  • Producing key compounds like vitamins and neurotransmitters.

  • Maintaining metabolic and mental well-being.

When the gut microbiome is imbalanced (dysbiosis), it can lead to issues such as digestive disorders, chronic diseases, and mental health challenges.

What the GHT Report

Provides

GHT report is synthesised from global research, AMILI's collaborations with institutions, and AMILI's own proprietary research to offer :

  • Functional Health Scores: Gut brain Axis, Immunity, and Digestive pathway insights.

  • Personalised Recommendations: Probiotic strains, dietary guidance, and lifestyle changes tailored to patient needs.

  • Risk Assessment: Disease-associated profiles for early detection and intervention planning.

Why Test

the Gut Microbiome?

Reveal the Hidden

Many health issues develop subtly and are missed by traditional tests. Gut microbiome testing uncovers imbalances and markers often overlooked in conventional diagnostics.

Gain Next-Level Insights

Next-gen sequencing provides in-depth analysis of the gut microbiome, linking microbial compositions to specific disease risks and health pathways.

Enhance Patient Care

The GHT report helps clinicians:


· Identify areas of microbial imbalance affecting health outcomes.
· Implement evidence-based interventions like probiotics or dietary changes.
· Track patien

t progress with actionable data and measurable outcomes.

Monitor Progress Over Time

The GHT screening is a valuable tool for tracking the efficacy of interventions and adjusting treatment plans to improve patient health.

Enable Targeted Solutions

AMILI’s GHT report recommends specific probiotic strains tailored to each patient, ensuring the best outcomes through personalised care.

Practical

Interventions

for Gut Health

The GHT screening helps inform actionable strategies for improving gut health, such as:

Dietary
Adjustments

Incorporating foods rich in probiotics and prebiotics.

Probiotics and Prebiotics

Targeted formulations to support beneficial bacteria.

Lifestyle Modifications

Regular exercise and stress management for microbiome diversity.

Advanced
Therapies

Options like Fecal Microbiota Transplants (FMT) for severe dysbiosis.

Why

Partner

with AMILI?

Data-Driven Precision

Insights tailored to diverse Asian populations using our proprietary database.

Research Excellence

Backed by partnerships with leading global institutions.

Specificity

We are in Asia, for Asians; Reports designed for Asians, those who eat Asian food and the Asian Diaspora because the microbiome differs so much between the west and Asia. Local food recommendations to improve gut health, and so much more.

Expand Preventative Care Services

Use microbiome screenings as a foundation for preventative care strategies, reducing long-term healthcare costs for patients while creating ongoing value.

Empowering Health, Fitness and Allied Professionals with

Cutting-Edge Insights

Our reports are meticulously designed to enable healthcare professionals to make informed clinical decisions and craft actionable, personalized care plans. By integrating our microbiome screening into their practice, HCPs can:

Enhance Patient Outcomes

Leverage precise microbiome insights to address gut health challenges effectively, driving better health results for patients.

Stay Ahead with Science

Access the latest advancements in microbiome research, ensuring their care is grounded in the forefront of scientific discovery.

Differentiate Their Practice

Offer innovative solutions that add tangible value to patient care, positioning themselves as leaders in modern healthcare.

Transform

Gut Health with AMILI

Through our commitment to scientific excellence and actionable insights, we empower HCPs to deliver next-level care and improve lives.

Partner with us to revolutionise patient care through cutting-edge microbiome science. Explore the GHT screening today and provide your patients with the personalized insights they need for better health outcomes.